1. Introduction {#sec1}
===============

Molecular docking is a method in which it is attempted to find the most probable pose of the ligand in the active site of a receptor and estimation of the binding energy. Molecular docking is a computational approach whose applicability in virtual screening was approved. Comparing with experimental methods of HTS (High Throughput Screening) it can save time and cost of a drug discovery project. However, it suffers from some drawbacks such as a high rate of false positives \[[@B1], [@B2]\]. It was shown that docking programs have a reasonable power to predict correct binding pose of the ligands. However, their scoring powers were not same for different protein families and also there is a weak correlation between docked scores and binding affinities of the ligands \[[@B3], [@B4]\].

One of the most cited open source docking engines is AutoDock Vina \[[@B5]\]. It uses genetic algorithm to search for the most energy favorable pose of a flexible small molecule in either a rigid or a flexible binding site of a protein. Here, AutoDock Vina was employed as a docking engine. Generally, the docking engines use scoring functions to discriminate between favorable and unfavorable binding poses of the same molecule \[[@B6]\]. Furthermore, scoring functions rank the best binding poses of the different small molecules to find strong binders among them. The scoring functions deal with a trade-off between speed and accuracy. Thus, rescoring and consensus scoring approaches have been investigated to discover a stable method that possibly could add up the accuracy of various scoring functions and outperform single scoring functions \[[@B7]--[@B11]\]. However, it has been suggested that the scoring functions performances are target dependent. However, the present study is different in some aspects. The data set is retrieved from DUD-E \[[@B12]\] data set to avoid bias in the design of active groups and decoys data set for each protein target. In addition, the protein targets data set is diverse and we attempted to find possible relationships between scoring function performances and the binding site descriptors.

One of the proposed solutions that possibly could improve the virtual screening results is rescoring. Scoring functions can fall into three categories \[[@B6], [@B13]\]: (1) empirical scoring functions, including ChemScore \[[@B14]\], (2) knowledge-based potentials, including DrugScore \[[@B15]\], and (3) force-field based approaches, including AutoDock Vina \[[@B5]\] and AutoDock 4.2 \[[@B16]\]. Four metrics can be employed to assess the performance of a scoring function: the scoring power, ranking power, docking power, and screening power \[[@B6], [@B17]\]. Thus, rescoring can be done to find the best conformation of a single molecule (improvement of docking power) and for improvement of estimation of the binding energy and ranking the ligands (scoring and ranking power) or reranking the hits of a virtual screening to discriminate between decoys and true binders (improvement of screening power). The latter is the main concept of this research. A consensus scoring method so-called rank-by-number that had shown promising results \[[@B9]\] was also tested in this study. Several reports \[[@B1], [@B7]--[@B11]\] investigated the possible effects of rescoring on the different metrics of scoring performance. Among them the main result of more recent studies that have been done on larger data sets is that scoring function performance is very dependent on target \[[@B1]\]. In the other words, the current scoring functions are not universal.

In this study it was attempted to evaluate rescoring performance in virtual screenings conducted on a large set of predefined ligands and decoys for 32 receptors. In addition, the aim of this study is to find a method to predict the performance of a scoring function on specific targets. This study seeks to address two questions. (1) Can employed rescoring strategies consistently improve discrimination binders from decoys? (2) Can the performance of docking and/or scoring be predicted by specification of the receptors binding sites?

2. Methods {#sec2}
==========

2.1. Receptors and Ligand Preparation {#sec2.1}
-------------------------------------

32 diverse targets were selected from the DUD-E database \[[@B12]\] ([Table 1](#tab1){ref-type="table"}). The selection was based on the diversity and size of the set to keep the computational cost as low as possible. The same 3D structures that had been used in DUD-E for each of the 32 selected targets were retrieved from protein data bank (PDB) ([Table 1](#tab1){ref-type="table"}). Then, the PDB files were prepared for AutoDock Vina docking. Cocrystal ligands and water molecules were removed, hydrogen and partial charges (Gasteiger) were added, and the coordinates of the 3D structures were saved in pdbqt format. The ligands from the DUD-E data set were used following modifications. The ligands in the DUD-E set have been divided into active compounds and decoy compounds for each target. There are approximately 50 decoys for each active compound in the whole DUD-E set. The active group contained some duplicate structures that differ in their protonation states. As this would generate an analog bias, the duplicate forms were omitted, and only a single structure, which was in its physiological protonation state, was kept. The corresponding decoy structures were also omitted from the study. All the ligands were converted to pdbqt files. The number of active groups and decoys for each target were reported in [Table 1](#tab1){ref-type="table"}.

2.2. Virtual Screening {#sec2.2}
----------------------

The AutoDock Vina was employed for the molecular docking \[[@B5]\]. For each of the targets, a box was defined to dock the ligands properly in each active site. In all the docking runs, the exhaustiveness was set to 8. The cocrystal ligand for each target was redocked in the binding site of the target and the results are available as in Supplementary Materials ([available here](#supplementary-material-1){ref-type="supplementary-material"}).

2.3. Rescoring {#sec2.3}
--------------

Four scoring functions and combinations of them have been evaluated in this study. These four scoring methods were from three different categories. Vina scoring (built-in scoring function of AutoDock Vina) and AutoDock4.2 scoring functions are force-field based. ChemScore is a SYBYL built-in scoring function that is an empirical scoring function. DrugScore is a knowledge base scoring function and is available as a standalone scoring function. All of the best docked poses of the ligands based on the Vina scoring function were rescored by other three scoring functions and also by all possible combinations. Thus, 11 consensus scorings were also applied (Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}).

A previously defined consensus scoring (rank-by-number method \[[@B9]\]) was employed to summarize the results of multiple scoring functions. Rank-by-number consensus score is an average of the *Z*-scaled scores calculated by each of the individual scoring functions. Individual *Z*-scaled scoring function values (*Z*Score) are computed by$$\begin{matrix}
{Zscore = \frac{\left( {fi - \mu} \right)}{S},} \\
\end{matrix}$$where *fi* is the scoring value of an individual scoring function, *μ* is the mean value, and *S* is the standard deviation of this scoring function for entire set.

2.4. Calculation of Binding Site Descriptors {#sec2.4}
--------------------------------------------

Binding site environment properties were retrieved form PLIC \[[@B18]\] database. This is a database that provides cluster of binding sites. It uses Fpocket \[[@B19]\] and LPC \[[@B20]\] to generate the following binding site descriptors: pocket volume, number of alpha spheres, mean alpha sphere radius, proportion of apolar alpha spheres, mean local hydrophobic density, hydrophobicity scores, volume score, charge score, proportion of polar atoms, alpha sphere density, maximum distance between COM and alpha sphere, Maximum Theoretical Shape Complementarity, observed shape complementarity, and normalized shape complementarity.

2.5. Statistical Analysis {#sec2.5}
-------------------------

To assess the performance of each scoring function and the consensus scoring two parameters were used: area under the curve (AUC) of the ROC (receiver operating characteristic) curve and enrichment factor (EF) at different levels. To evaluate the performance of the scoring functions in discriminating active groups among decoys the scoring functions performance was tested on docked active and decoy compounds. The ROC curve and EF were applied to determine the performance of each scoring function. The increase in AUC of the ROC curve can be used as an indicator of improvement in discrimination between true ligands from decoys. AUC can have a value between 0 and 1, in which AUC = 0.5 means that the method of interest performed like a random selection in average, while AUC = 1 means the complete discrimination between true and false cases (active and decoys). EF is defined as the fraction of active compounds found divided by the fraction of the screened library: $$\begin{matrix}
{EF = \frac{actives_{sampled}}{actives_{total}} \times \frac{N_{total}}{N_{sampled}}.} \\
\end{matrix}$$

EF1% and EF2% showed the ability of a particular scoring method to retrieve true ligands with a high rank among virtual screening results.

Significance of the difference between the AUC of the two ROC curves was assessed using online tool at <http://vassarstats.net/roc_comp.html>. Other statistical tests and plotting were done using R (R: a language and environment for statistical computing; R Foundation for Statistical Computing, Vienna, Austria; URL <http://www.R-project.org/>) including the following packages: enrichvs and ROCR.

3. Results {#sec3}
==========

The average and difference in AUC of the ROC curve for each scoring method after rescoring are presented in Tables [2](#tab2){ref-type="table"} and [3](#tab3){ref-type="table"}, respectively. They show the overall performance for each scoring method. The individual AUC of the ROC curve were shown in [Table 4](#tab4){ref-type="table"} and the details for each receptor and AutoDock Vina configuration files were presented in Supplementary Materials. The correlation between different scoring strategies and binding site descriptors was shown in [Table 5](#tab5){ref-type="table"}. Screening power of AutoDock Vina original scoring and DrugScore demonstrated a good correlation with values of both Maximum Theoretical Shape Complementarity (MTSC) and Maximum Distance from Center of Mass and all Alpha spheres (MDCMA). [Figure 1](#fig1){ref-type="fig"} demonstrated this fair correlation between DrugScore performance and the binding site descriptor, MTSC. In [Table 6](#tab6){ref-type="table"} the protein targets whose AUC of the ROC curve were significantly increased or decreased after rescoring by DrugScore were emphasized ([Figure 2](#fig2){ref-type="fig"}). According to the various classifications plot (data not shown) it was found out that these two groups can be separated based on two descriptors, volume score and MTSC ([Figure 3](#fig3){ref-type="fig"}).

4. Discussion {#sec4}
=============

The calculated performance of AutoDock Vina on individual target can be used for selection of this docking engine for virtual screenings on specific targets. Furthermore, the results showed slight general improvement in discrimination between decoys and ligands by using consensus rescoring method which consisted of Vina and DrugScore scoring functions. By active site analysis it was shown that DrugScore improved the discrimination power of AutoDock Vina significantly in case of receptors that had both high volume score and MTSC. In addition, it was shown that AutoDock and DrugScore Screening powers had significant correlation with MTSC and MDCMA.

AutoDock Vina is free for academics and has showed a good scoring power in a recent study on large and diverse data set \[[@B4]\]. Thus, it was selected as a docking engine for pose prediction in the present study. The screening power of AutoDock Vina was correlated with MTSC and MDCMA. The reported AUC of the ROC curve and enrichment factor could be used for prediction of AutoDock Vina performance on each target. Furthermore, MTSC and MDCMA values could be used as a possible indicator of successfulness of AutoDock Vina in a virtual screening on a specific target protein. It was suggested \[[@B21]\] that AutoDock Vina had a better average performance for 31 protein targets\' virtual screening than DOCK \[[@B22]\]. As AutoDock Vina is an open source and shows good performance compared with other docking engines, improvements of AutoDock Vina code in different aspects such as parallel run \[[@B23]\] have been conducted during recent years.

It was suggested that the performances of docking program and scoring functions were target dependent \[[@B1], [@B4]\]. The nature of the active site of the proteins, the choice of scoring functions, and the set of ligands used for comparisons all affected the performance in scoring and ranking compounds \[[@B11]\]. Some studies concluded that consensus scoring (rank-by-number, consisting of three or four scoring functions) outperformed individual scoring performance \[[@B9]\]. In most of the studies that were conducted on more diverse and larger data sets, there is no strong correlation between affinity and scoring function predictions \[[@B4], [@B10]\]. In this study, only the ranking power of the scoring function was estimated. In overall consensus scoring with both DrugScore and Vina scoring functions, rescoring with DrugScore slightly improved the ranking metrics (AUC of the ROC curve and EF), but it was not statistically significant.

Rescoring by DrugScore produces most cases with significant increased or decreased screening power (assessed by changes in the AUC of the ROC curve) with respect to the original Vina scoring. Therefore, these data were used to find possible binding site descriptors that could predict the performance of DrugScore rescoring in improvement of original virtual screening results. Finally, after exploring different descriptors it was found that a simple model based on two descriptors (volume score and MTSC) could fairly predict the improvement of virtual screening results after rescoring by DrugScore for a target protein. DrugScore has been also successful in some other rescoring campaigns \[[@B8], [@B24]\] and was one of the best performers in a ranking power assessment among 16 scoring functions \[[@B7]\].

MTSC indicates the shape complementarity of a binding site with the specific cocrystalized ligand. Here, it was shown that the performance of DrugScore as well as AutoDock Vina docking and subsequent scoring are correlated with the value of MTSC. It could be due to the better performance of AutoDock Vina docking algorithm in finding near native pose of active groups in the case of a binding site with high MTSC. The values of the volume score descriptor were correlated with the improvement of virtual screening results by DrugScore rescoring. This could be explained as better performance of DrugScore in the case of the higher number of ligand-protein interactions in the bigger binding sites.

5. Conclusion {#sec5}
=============

The results consistent with those previous studies suggested that performance of docking and scoring functions was target specific. Working on new scoring functions that include terms for aromatic-aromatic or *π*-cation or halogen protein interactions has been suggested. A correlation between screening power of AutoDock Vina and DrugScore and two binding site descriptors, MTSC and MDCMA, was found. The improvement after rescoring with DrugScore was predicted by two descriptors: volume score and MTSC. The ultimate goal of this study was to determine which of the scoring functions or combinations of them would yield the best results in terms of enrichment when used in a virtual screening study. The results could provide useful information for people to select the most appropriate target for using AutoDock Vina and/or DrugScore in their studies.
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Supplementary Materials {#supplementary-material-1}
=======================

###### 

Supplementary Materials contain a folder (configuration files) which includes the configuration files of the AutoDock Vina, a Microsoft Excel file (RMSD-redocking) which includes all of the RMSD obtained after redocking the cocrystal ligands in each corresponding target active site, and another Microsoft Excel file (rescoring-details) which includes detailed results of the rescoring study on each protein target.

###### 

Click here for additional data file.

![Significant correlation between performance of DrugScore and MTSC descriptor (correlation coefficient = 0.719, *p* value \< 0.001).](IJMC2018-3829307.001){#fig1}

![The cases with significant improvement in AUC of the ROC curves after rescoring with DrugScore (before: blue line; after: red dots).](IJMC2018-3829307.002){#fig2}

![Separation of good and bad responders to DrugScore rescoring based on volume score and MTSC descriptors.](IJMC2018-3829307.003){#fig3}

###### 

Data set characteristics.

  Abbreviation used in DUD-E   Target name                                                                               PDB code   Number of ligands   Number of decoys
  ---------------------------- ----------------------------------------------------------------------------------------- ---------- ------------------- ------------------
  ADA                          Adenosine deaminase                                                                        2E1W      93                  5444
  AKT2                         Serine/threonine-protein kinase AKT2                                                       3D0E      116                 6891
  COMT                         Catechol O-methyltransferase                                                               3BWM      41                  3846
  CP2C9                        Cytochrome P450 2C9                                                                        1R9O      120                 7435
  CXCR4                        C-X-C chemokine receptor type 4                                                            3ODU      40                  3406
  DEF                          *E. coli* peptide deformylase complexed with antibiotic actinonin                          1LRU      102                 5686
  FA7                          Coagulation factor VII                                                                    1W7X       114                 6239
  FKB1A                        FK506-binding protein 1A                                                                   1J4H      111                 5797
  GLCM                         Beta-glucocerebrosidase                                                                    2V3F      54                  3799
  GRIK1                        Glutamate receptor ionotropic kainate 1                                                    1VSO      101                 6540
  HS90A                        Heat shock protein HSP 90-alpha                                                            1UYG      88                  4848
  HXK4                         Hexokinase type IV (human pancreatic glucokinase in complex with glucose and activator)    3F9M      91                  4692
  INHA                         Enoyl-\[acyl-carrier-protein\] reductase (*Mycobacterium tuberculosis* enoyl reductase)    2H7L      43                  2297
  KIF11                        Kinesin-like protein 1                                                                     3CJO      116                 6844
  KITH                         Stem cell growth factor receptor (KIT kinase domain in complex with sunitinib)             2B8T      57                  2850
  MAPK2                        MAP kinase-activated protein kinase 2                                                      3M2W      101                 6144
  MCR                          Mineralocorticoid receptor                                                                 2AA2      90                  4835
  MK01                         MAP kinase ERK2                                                                            2OJG      79                  4548
  MK10                         c-Jun N-terminal kinase 3 (mitogen-activated protein kinase 10)                            2ZDT      104                 6593
  NOS1                         Nitric-oxide synthase, brain                                                               1QW6      100                 8037
  NRAM                         Neuraminidase (influenza virus neuraminidase)                                              1B9V      98                  6196
  PA2GA                        Phospholipase A2 group IIA                                                                 1KVO      99                  5143
  PLK1                         Serine/threonine-protein kinase PLK1                                                       2OWB      107                 6794
  PUR2                         GAR transformylase                                                                         1NJS      50                  2694
  PYGM                         Muscle glycogen phosphorylase                                                              1C8K      77                  3940
  PYRD                         Dihydroorotate dehydrogenase                                                               1D3G      111                 6443
  RENI                         Renin                                                                                      3G6Z      104                 6954
  ROCK1                        Rho-associated protein kinase 1                                                            2ETR      100                 6293
  SAHH                         Adenosylhomocysteinase                                                                     1LI4      62                  3438
  THB                          Thyroid hormone receptor beta-1                                                            1Q4X      103                 7349
  TYSY                         Thymidylate synthase                                                                      1SYN       109                 6732
  WEE1                         Serine/threonine-protein kinase WEE1                                                       3BIZ      102                 6135
  XIAP                         Inhibitor of apoptosis protein 3                                                          3HL5       100                 5143

###### 

Average of AUC of the ROC curve and EF at different level obtained with each scoring approach (*v*: AutoDock Vina, *c*: ChemScore, *d*: DrugScore, and *a*: AutoDock 4.2).

  Scoring   AUC     EF20%   EF10%   EF2%    EF1%    EF0.2%   EF0.1%
  --------- ------- ------- ------- ------- ------- -------- --------
  *v*       0.671   2.137   2.93    6.394   8.576   11.17    12.74
  *c*       0.61    1.855   2.33    3.567   4.007   4.513    3.54
  *d*       0.65    1.942   2.72    5.253   6.275   8.766    9.242
  *a*       0.623   1.831   2.5     4.441   4.949   7.301    8.866
  *vcda*    0.668   2.162   3.08    6.714   8.173   8.753    10.01
  *vcd*     0.667   2.174   3.01    6.537   8.768   9.746    9.515
  *vda*     0.677   2.2     3.21    7.096   9.169   11.72    14
  *vca*     0.661   2.088   3.01    5.989   7.25    8.371    7.76
  *cda*     0.652   2.068   2.84    5.158   6.086   7.41     7.47
  *vc*      0.656   2.087   2.93    6.233   7.28    7.564    7.415
  *vd*      0.679   2.14    3.08    7.026   9.292   13.21    14.76
  *va*      0.671   2.192   3.05    6.074   8.562   11.72    15.66
  *cd*      0.646   2.012   2.77    4.916   5.986   6.896    6.06
  *ca*      0.631   1.895   2.53    4.322   5.057   7.324    6.865
  *da*      0.658   2.026   2.85    5.579   7.182   8.688    8.51

###### 

Average of difference between each rescoring approach in terms of AUC of the ROC curve and EF and original AutoDock Vina scoring (*v*: AutoDock Vina, *c*: ChemScore, *d*: DrugScore, and *a*: AutoDock 4.2).

  Scoring        AUC      EF20%    EF10%    EF2%     EF1%     EF0.2%   EF0.1%
  -------------- -------- -------- -------- -------- -------- -------- --------
  *v* − *v*      0.000    0.000    0.000    0.000    0.000    0.000    0.000
  *c* − *v*      −0.061   −0.282   −0.600   −2.827   −4.569   −6.662   −9.201
  *d* − *v*      −0.021   −0.195   −0.211   −1.140   −2.301   −2.409   −3.499
  *a* − *v*      −0.048   −0.306   −0.432   −1.953   −3.627   −3.874   −3.875
  *vcda* − *v*   −0.003   0.026    0.144    0.321    −0.403   −2.421   −2.736
  *vcd* − *v*    −0.004   0.037    0.074    0.143    0.192    −1.429   −3.226
  *vda* − *v*    0.006    0.063    0.281    0.702    0.593    0.541    1.263
  *vca* − *v*    −0.010   −0.049   0.072    −0.405   −1.325   −2.804   −4.982
  *cda* − *v*    −0.019   −0.068   −0.091   −1.236   −2.490   −3.765   −5.271
  *vc* − *v*     −0.015   −0.050   −0.003   −0.161   −1.296   −3.611   −5.326
  *vd* − *v*     0.008    0.004    0.147    0.632    0.716    2.033    2.014
  *va* − *v*     0.000    0.055    0.119    −0.320   −0.014   0.543    2.920
  *cd* − *v*     −0.025   −0.124   −0.167   −1.478   −2.590   −4.279   −6.681
  *ca* − *v*     −0.040   −0.242   −0.399   −2.072   −3.519   −3.850   −5.877
  *da* − *v*     −0.013   −0.111   −0.084   −0.814   −1.394   −2.487   −4.231

###### 

AUC of the ROC curve obtained with each scoring method for individual targets (*v*: AutoDock Vina, *c*: ChemScore, *d*: DrugScore, and *a*: AutoDock 4.2; sorted based on AutoDock Vina performance).

          *v*     *c*     *d*     *a*     *vcda*   *vcd*   *vda*   *vca*   *cda*   *vc*    *vd*    *va*    *cd*    *ca*    *da*
  ------- ------- ------- ------- ------- -------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  WEE1    0.949   0.828   0.841   0.555   0.917    0.909   0.927   0.915   0.853   0.916   0.930   0.910   0.852   0.776   0.800
  FA7     0.917   0.890   0.876   0.878   0.929    0.936   0.926   0.927   0.909   0.935   0.929   0.920   0.908   0.897   0.898
  MAPK2   0.886   0.775   0.776   0.717   0.877    0.850   0.877   0.888   0.848   0.861   0.849   0.891   0.809   0.826   0.823
  KIF11   0.858   0.845   0.806   0.840   0.860    0.860   0.856   0.865   0.846   0.867   0.852   0.864   0.842   0.849   0.835
  TYSY    0.847   0.607   0.698   0.770   0.781    0.768   0.820   0.778   0.726   0.760   0.822   0.829   0.675   0.710   0.762
  PYRD    0.826   0.749   0.768   0.730   0.791    0.807   0.795   0.784   0.767   0.803   0.817   0.789   0.778   0.747   0.763
  PUR2    0.819   0.393   0.856   0.691   0.749    0.762   0.827   0.667   0.702   0.641   0.869   0.777   0.696   0.557   0.801
  MK01    0.806   0.767   0.632   0.629   0.748    0.777   0.719   0.774   0.702   0.816   0.747   0.748   0.726   0.721   0.639
  AKT2    0.778   0.744   0.699   0.803   0.801    0.788   0.810   0.794   0.795   0.776   0.786   0.806   0.765   0.785   0.799
  THB     0.777   0.484   0.490   0.578   0.632    0.630   0.665   0.700   0.504   0.693   0.670   0.777   0.480   0.523   0.510
  MK10    0.746   0.701   0.653   0.598   0.694    0.721   0.682   0.697   0.666   0.737   0.716   0.684   0.692   0.659   0.633
  FKB1A   0.693   0.755   0.657   0.668   0.730    0.745   0.697   0.734   0.724   0.755   0.702   0.690   0.738   0.736   0.676
  INHA    0.688   0.680   0.715   0.693   0.719    0.722   0.719   0.708   0.712   0.705   0.723   0.702   0.712   0.696   0.714
  KITH    0.688   0.532   0.699   0.621   0.646    0.655   0.667   0.628   0.632   0.631   0.692   0.654   0.636   0.592   0.658
  SAHH    0.677   0.290   0.708   0.615   0.590    0.575   0.719   0.516   0.539   0.478   0.726   0.685   0.512   0.391   0.694
  ROCK1   0.666   0.660   0.594   0.654   0.668    0.662   0.659   0.678   0.657   0.680   0.642   0.674   0.645   0.666   0.641
  CXCR4   0.661   0.726   0.604   0.723   0.706    0.687   0.685   0.729   0.706   0.718   0.640   0.712   0.682   0.735   0.681
  XIAP    0.632   0.676   0.789   0.678   0.724    0.739   0.722   0.681   0.741   0.669   0.741   0.668   0.772   0.694   0.742
  RENI    0.620   0.686   0.781   0.588   0.694    0.733   0.688   0.638   0.707   0.664   0.742   0.605   0.759   0.642   0.703
  PLK1    0.619   0.628   0.668   0.548   0.628    0.653   0.625   0.605   0.625   0.629   0.659   0.588   0.659   0.592   0.620
  CP2C9   0.613   0.604   0.552   0.563   0.597    0.607   0.588   0.605   0.582   0.622   0.593   0.597   0.588   0.587   0.564
  PA2GA   0.607   0.795   0.692   0.814   0.791    0.760   0.768   0.783   0.812   0.746   0.696   0.744   0.771   0.821   0.801
  PYGM    0.594   0.597   0.561   0.446   0.561    0.597   0.543   0.555   0.540   0.608   0.583   0.530   0.588   0.522   0.502
  NOS1    0.570   0.551   0.506   0.492   0.545    0.545   0.533   0.570   0.533   0.570   0.533   0.569   0.533   0.551   0.506
  DEF     0.541   0.262   0.632   0.578   0.502    0.465   0.602   0.456   0.485   0.384   0.602   0.569   0.427   0.415   0.621
  GRIK1   0.538   0.464   0.492   0.442   0.483    0.500   0.493   0.480   0.460   0.503   0.518   0.495   0.480   0.439   0.467
  NRAM    0.526   0.522   0.608   0.443   0.537    0.574   0.537   0.496   0.537   0.530   0.581   0.478   0.589   0.481   0.536
  COMT    0.525   0.371   0.363   0.736   0.575    0.398   0.645   0.646   0.593   0.431   0.439   0.750   0.340   0.688   0.690
  ADA     0.520   0.377   0.500   0.435   0.438    0.444   0.479   0.428   0.417   0.430   0.509   0.474   0.416   0.395   0.459
  HX4     0.515   0.552   0.590   0.534   0.550    0.554   0.549   0.533   0.563   0.532   0.555   0.524   0.573   0.545   0.566
  MCR     0.498   0.656   0.639   0.563   0.628    0.634   0.571   0.589   0.691   0.584   0.571   0.495   0.699   0.665   0.634
  GLCM    0.486   0.471   0.548   0.541   0.520    0.506   0.536   0.506   0.528   0.484   0.517   0.520   0.515   0.507   0.559
  HS90A   0.250   0.321   0.393   0.369   0.308    0.290   0.295   0.316   0.346   0.270   0.296   0.294   0.338   0.310   0.378

###### 

Pearson correlation coefficients between each rescoring approach and binding site descriptors (*v*: AutoDock Vina, *c*: ChemScore, *d*: DrugScore, and *a*: AutoDock 4.2).

           Pocket volume   Number of alpha spheres   Mean alpha sphere radius   Proportion of apolar alpha spheres   Mean local hydrophobic density   Hydrophobicity score   Volume score   Charge score   Proportion of polar atoms   Alpha sphere density   Max Dist. from Center of Mass and all Alpha spheres   Maximum Theoretical Shape Complementarity   Observed shape complementarity   Normalized shape complementarity
  -------- --------------- ------------------------- -------------------------- ------------------------------------ -------------------------------- ---------------------- -------------- -------------- --------------------------- ---------------------- ----------------------------------------------------- ------------------------------------------- -------------------------------- ----------------------------------
  *v*      0.415           0.418                     −0.055                     0.001                                0.249                            −0.108                 −0.190         0.170          0.098                       0.458                  0.594                                                 0.532                                       0.439                            0.085
  *c*      0.509           0.400                     0.068                      0.126                                0.266                            0.131                  −0.153         0.320          −0.204                      0.445                  0.459                                                 0.462                                       0.304                            −0.042
  *d*      0.510           0.387                     0.111                      −0.066                               0.161                            −0.011                 0.014          0.171          0.141                       0.366                  0.555                                                 0.719                                       0.474                            −0.022
  *a*      0.234           0.355                     0.034                      0.095                                0.217                            0.103                  0.135          0.268          −0.118                      0.207                  0.378                                                 0.413                                       0.303                            0.030
  *vcda*   0.483           0.424                     0.061                      0.058                                0.274                            0.001                  −0.057         0.307          −0.041                      0.419                  0.586                                                 0.607                                       0.415                            −0.005
  *vcd*    0.541           0.471                     0.064                      0.031                                0.276                            0.017                  −0.142         0.274          −0.011                      0.483                  0.620                                                 0.665                                       0.464                            0.000
  *vda*    0.417           0.387                     0.043                      0.010                                0.234                            −0.081                 −0.011         0.243          0.051                       0.363                  0.573                                                 0.588                                       0.425                            0.035
  *vca*    0.443           0.410                     0.028                      0.104                                0.295                            0.011                  −0.083         0.328          −0.105                      0.425                  0.557                                                 0.515                                       0.365                            0.005
  *cda*    0.476           0.378                     0.085                      0.080                                0.244                            0.068                  0.028          0.334          −0.095                      0.361                  0.519                                                 0.582                                       0.356                            −0.056
  *vc*     0.515           0.468                     0.031                      0.073                                0.302                            0.022                  −0.202         0.292          −0.073                      0.507                  0.596                                                 0.562                                       0.413                            0.015
  *vd*     0.495           0.454                     0.031                      −0.025                               0.241                            −0.074                 −0.112         0.187          0.112                       0.453                  0.631                                                 0.684                                       0.506                            0.045
  *va*     0.331           0.354                     −0.012                     0.043                                0.241                            −0.089                 −0.036         0.247          0.011                       0.349                  0.532                                                 0.459                                       0.365                            0.064
  *cd*     0.554           0.426                     0.100                      0.033                                0.234                            0.087                  −0.086         0.292          −0.048                      0.439                  0.553                                                 0.651                                       0.409                            −0.058
  *ca*     0.412           0.339                     0.061                      0.148                                0.250                            0.116                  0.022          0.346          −0.212                      0.337                  0.436                                                 0.439                                       0.272                            −0.047
  *da*     0.379           0.336                     0.075                      0.023                                0.184                            −0.002                 0.143          0.269          0.009                       0.260                  0.479                                                 0.567                                       0.366                            −0.017

###### 

Difference between calculated AUC of the ROC curve after rescoring with DrugScore and original AUC of the ROC curve for each target (^*∗*^statistically significant changes).

  Receptor     *d* − *v*
  ------------ -----------
  THB^*∗*^     −0.2876
  MK01^*∗*^    −0.1738
  COMT^*∗*^    −0.1625
  TYSY^*∗*^    −0.1491
  WEE1^*∗*^    −0.1083
  MK10^*∗*^    −0.0929
  AKT2^*∗*^    −0.0787
  ROCK1        −0.0715
  NOS1         −0.0641
  CP2C9        −0.0605
  PYRD         −0.0582
  CXCR4        −0.0569
  KIF11        −0.0518
  GRIK1        −0.0467
  FA7          −0.0403
  FKB1A        −0.036
  PYGM         −0.0327
  ADA          −0.02
  KITH         0.0107
  INHA         0.0262
  SAHH         0.0303
  PUR2         0.0364
  PLK1         0.0492
  GLCM         0.062
  HX4          0.0753
  NRAM         0.0812
  PA2GA^*∗*^   0.0854
  DEF^*∗*^     0.0906
  MCR^*∗*^     0.1411
  HS90A^*∗*^   0.1439
  XIAP^*∗*^    0.1577
  RENI^*∗*^    0.1605

[^1]: Academic Editor: Patrick J. Bednarski
